Skip to main content
. 2022 Sep 26;2022:4758189. doi: 10.1155/2022/4758189

Table 6.

Key targets of YGJ and YGJ-BBB.

Group KEGG pathway Key targets
YGJ PI3K-Akt signaling pathway AKT1, CCND1, BCL2, EGFR, ERBB2, ERBB4, FGFR1, MTOR, GSK3B, GYS1, HSP90AA1, IGF1R, IL2, INSR, JAK2, KIT, MCL1, NOS3, NTRK1, PDGFRB, PIK3CA, PRKAA1, MAPK1, MAP2K1, RXRA, VEGFA
YGJ-BBB Endocrine resistance AKT1, CCND1, BCL2, BRAF, EGFR, ERBB2, ESR1, ESR2, MTOR, IGF1R, MMP2, MMP9, PIK3CA, MAPK1, MAP2K1